Pictet Asset Management Holding Sa Arcus Biosciences, Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 10,452 shares of RCUS stock, worth $100,443. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,452Holding current value
$100,443% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding RCUS
# of Institutions
201Shares Held
62.4MCall Options Held
116KPut Options Held
116K-
Black Rock Inc. New York, NY9.76MShares$93.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.69MShares$64.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA5.13MShares$49.3 Million0.28% of portfolio
-
State Street Corp Boston, MA3.7MShares$35.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.87MShares$27.6 Million0.06% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $693M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...